Hólyagrák: nyitott vizsgálatok itt: Görögország
8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. nov. 10.. Ask the study team whether a trial fits you.
3. fázisToborozTrial-stage medicine
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Where
- Athens, Efkarpia, Maroussi, Patras, Thessaloniki
- Age
- 18 év and over
- People
- 220 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06919965EU 2024-519493-39-00Regiszter frissítve: 2026-11-03
3. fázisToborozTrial-stage medicine
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
- Where
- Chaïdári, Cholargos, Kifissia, Maroussi, Thessaloniki
- Age
- 18 év and over
- People
- 590 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07419295EU 2024-520014-22-00Regiszter frissítve: 2026-11-03
2/3. fázisToborozResearch participation
Dato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC.
- Where
- Athens, Chaïdári, Efkarpia, Larissa, Maroussi, Patras, Pireas, Thessaloniki
- Age
- 18 év and over
- People
- 343 worldwide
- Run by
- Daiichi Sankyo Inc.
See details and how to join2024-516906-47-00EU 2024-516906-47-00Regiszter frissítve: 2026-10-29
1/2. fázisToborozTrial-stage medicine
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
- Where
- Thessaloniki
- Age
- 18 év and over
- People
- 45 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07222488EU 2025-520467-40-00Regiszter frissítve: 2026-10-29
1. fázisToborozResearch participation
A FIH study to investigate the safety and preliminary efficacy of expanded autologous urothelial cells bioprinted during orthotopic neobladder surgery
- Where
- Athens
- Age
- 18 év and over
- People
- 6
- Run by
- Phosprint S.A.
See details and how to join2025-522963-14-00EU 2025-522963-14-00Regiszter frissítve: 2026-10-23
2. fázisToborozTrial-stage medicine
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Where
- Athens, Chaïdári, Cholargos, Thessaloniki
- Age
- 18 év and over
- People
- 308 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06833073EU 2024-517335-46-00Regiszter frissítve: 2026-10-01
1/2. fázisToborzás még nem indultResearch participation
Extension Study of the U-LaserPrint-1 Clinical Trial
- Where
- Athens
- Age
- 18 év and over
- People
- 6
- Run by
- Phosprint S.A.
See details and how to join2026-527804-26-00EU 2026-527804-26-00Regiszter frissítve: 2026-09-17
3. fázisToborozResearch participation
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study with Durvalumab
- Where
- Kifissia
- Age
- 18 év and over
- People
- 87 worldwide
- Run by
- Astrazeneca AB
See details and how to joinNCT05303532EU 2023-507337-22-00Regiszter frissítve: 2026-09-08
Minden vizsgálat (Hólyagrák) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.